Evidence map›Paper›PMID 39014377›Full record

Observational studyCritical care (London, England)2024

Identification and transcriptomic assessment of latent profile pediatric septic shock phenotypes.

Mihir R Atreya, Min Huang, Andrew R Moore, Hong Zheng, Yehudit Hasin-Brumshtein, Julie C Fitzgerald, Scott L Weiss, Natalie Z Cvijanovich, Michael T Bigham, Parag N Jain and 19 more

Abstract readObservational StudyMulticenter Study
In one paragraph

Observational study in Critical care (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Observational
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Role of Tie-2 Axis in Sepsis: A Potential Therapeutic Target.Journal of cellular and molecular medicine · 2025
    Review
  8. Derivation and Validation of Pediatric Sepsis-Associated Acute Kidney Injury Subphenotypes With Prognostic Relevance.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2025
    Observational
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Mihir R AtreyaDivision of Critical Care Medicine, MLC2005, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA. Mihir.Atreya@cchmc.org.
Min HuangDepartment of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA, USA.
Andrew R MooreStanford Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
Hong ZhengStanford Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
Yehudit Hasin-BrumshteinInflammatix, Sunnyvale, CA, 94085, USA.
Julie C FitzgeraldChildren's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Scott L WeissNemours Children's Health, Wilmington, DE, 19803, USA.
Natalie Z CvijanovichUCSF Benioff Children's Hospital Oakland, Oakland, CA, 94609, USA.
Michael T BighamAkron Children's Hospital, Akron, OH, 44308, USA.
Parag N JainTexas Children's Hospital, Baylor College of Medicine, Houston, TX, 77030, USA.
Adam J SchwarzChildren's Hospital of Orange County, Orange, CA, 92868, USA.
Riad LutfiRiley Hospital for Children, Indianapolis, IN, 46202, USA.
Jeffrey NowakChildren's Hospital and Clinics of Minnesota, Minneapolis, MN, 55404, USA.
Neal J ThomasPenn State Hershey Children's Hospital, Hershey, PA, 17033, USA.
Michael QuasneyC.S Mott Children's Hospital, University of Michigan, Ann Arbor, MI, 48109, USA.
Mary K DahmerC.S Mott Children's Hospital, University of Michigan, Ann Arbor, MI, 48109, USA.
Torrey BainesUniversity of Florida Health Children's Hospital, Gainesville, FL, 32610, USA.
Bereketeab HaileselassieLucile Packard Children's Hospital Stanford, Palo Alto, CA, 94304, USA.
Andrew J LautzDivision of Critical Care Medicine, MLC2005, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA.
Natalja L StanskiDivision of Critical Care Medicine, MLC2005, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA.
Stephen W StandageDivision of Critical Care Medicine, MLC2005, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA.
Jennifer M KaplanDivision of Critical Care Medicine, MLC2005, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA.
Basilia ZingarelliDivision of Critical Care Medicine, MLC2005, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA.
Rashmi SahayDivision of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Bin ZhangDivision of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Timothy E SweeneyInflammatix, Sunnyvale, CA, 94085, USA.
Purvesh KhatriStanford Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
L Nelson Sanchez-PintoDepartment of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.
Rishikesan KamaleswaranDepartment of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA, 30322, USA.

Funding

Pediatric COVID-19 Severity Dashboard During Delta Variant CirculationR01HD105939 · NICHD · UNIVERSITY OF COLORADO DENVER · PI Tellen Bennett, Lazaro Nelson Sanchez-Pinto · 2021 to 2026
$4.6M
Stanford Training Program in Lung BiologyT32HL129970 · NHLBI · STANFORD UNIVERSITY · PI CORNFIELD, DAVID N., NICOLLS, MARK ROBERT · 2016 to 2025
$3.2M
ENdotypes in Children with Severe Acute Respiratory Distress SyNdrome: ImpAct on REsponse to Treatment (ENSNARE)R01HL149910 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAHMER, MARY K, FLORI, HEIDI R · 2020 to 2023
$2.9M
Sepsis Physiomarkers for Appropriate Risk Knowledge of monitored patients in the ICU (SPARK-ICU)R01GM139967 · NIGMS · EMORY UNIVERSITY · PI KAMALESWARAN, RISHIKESAN · 2021 to 2025
$2.8M
Supplement for MIRA award_Wong_2021R35GM126943 · NIGMS · CINCINNATI CHILDRENS HOSP MED CTR · PI ALDER, MATTHEW N · 2018 to 2022
$2.7M
Leveraging multi-omics to maximize the scientific value of pediatric sepsis biorepository and advance patient endotypingR33GM151703 · NIGMS · CINCINNATI CHILDRENS HOSP MED CTR · PI Mihir R Atreya, Rishikesan Kamaleswaran · 2025 to 2026
$1.4M
Translational approaches to unravel organ-specific microvascular endothelial responses in sepsis.R35GM155165 · NIGMS · CINCINNATI CHILDRENS HOSP MED CTR · PI Mihir R Atreya · 2024 to 2026
$1.2M
Pediatric septic acute kidney injury: personalizing antibiotic dosing through understanding acute kidney injury risk factors and biomarker profilesK23DK119463 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI FITZGERALD, JULIE C. HOLLOWS · 2020 to 2024
$810k
Developing a Precision Medicine Approach to Pediatric Sepsis-Associated Acute Kidney Injury: Identification of Unique Subphenotypes and Strategies for Bedside ImplementationK23GM151444 · NIGMS · CINCINNATI CHILDRENS HOSP MED CTR · PI Natalja L. Stanski · 2023 to 2026
$769k
Mechanisms of cardiomyocyte dysfunction in pediatric septic shockK08GM148957 · NIGMS · CINCINNATI CHILDRENS HOSP MED CTR · PI Andrew John Lautz · 2023 to 2026
$768k
Leveraging multi-omics to maximize the scientific value of pediatric sepsis biorepository and advance patient endotypingR21GM151703 · NIGMS · CINCINNATI CHILDRENS HOSP MED CTR · PI ATREYA, MIHIR R, KAMALESWARAN, RISHIKESAN · 2023 to 2024
$459k
Establishment of a multi-center biobank of patient-specific induced pluripotent stem cells for pediatric sepsis researchR21GM150093 · NIGMS · CINCINNATI CHILDRENS HOSP MED CTR · PI ATREYA, MIHIR R, LAUTZ, ANDREW JOHN · 2023 to 2024
$431k
National Institute of Child Health and Human Development R01HD105939NHLBI NIH HHS R01 HL149910NHLBI NIH HHS R01HL149910NHLBI NIH HHS T32 HL129970NICHD NIH HHS R01 HD105939NIDDK NIH HHS K23 DK119463NIGMS NIH HHS K08 GM148957NIGMS NIH HHS K23 GM151444NIGMS NIH HHS R01 GM139967NIGMS NIH HHS R21 GM150093NIGMS NIH HHS R21GM150093NIGMS NIH HHS R21 GM151703NIGMS NIH HHS R21GM151703NIGMS NIH HHS R33 GM151703NIGMS NIH HHS R35 GM126943NIGMS NIH HHS R35 GM155165
6 · The paper itself

Abstract

backgroundSepsis poses a grave threat, especially among children, but treatments are limited owing to heterogeneity among patients. We sought to test the clinical and biological relevance of pediatric septic shock subclasses identified using reproducible approaches.

methodsWe performed latent profile analyses using clinical, laboratory, and biomarker data from a prospective multi-center pediatric septic shock observational cohort to derive phenotypes and trained a support vector machine model to assign phenotypes in an internal validation set. We established the clinical relevance of phenotypes and tested for their interaction with common sepsis treatments on patient outcomes. We conducted transcriptomic analyses to delineate phenotype-specific biology and inferred underlying cell subpopulations. Finally, we compared whether latent profile phenotypes overlapped with established gene-expression endotypes and compared survival among patients based on an integrated subclassification scheme.

resultsAmong 1071 pediatric septic shock patients requiring vasoactive support on day 1 included, we identified two phenotypes which we designated as Phenotype 1 (19.5%) and Phenotype 2 (80.5%). Membership in Phenotype 1 was associated with ~ fourfold adjusted odds of complicated course relative to Phenotype 2. Patients belonging to Phenotype 1 were characterized by relatively higher Angiopoietin-2/Tie-2 ratio, Angiopoietin-2, soluble thrombomodulin (sTM), interleukin 8 (IL-8), and intercellular adhesion molecule 1 (ICAM-1) and lower Tie-2 and Angiopoietin-1 concentrations compared to Phenotype 2. We did not identify significant interactions between phenotypes, common treatments, and clinical outcomes. Transcriptomic analysis revealed overexpression of genes implicated in the innate immune response and driven primarily by developing neutrophils among patients designated as Phenotype 1. There was no statistically significant overlap between established gene-expression endotypes, reflective of the host adaptive response, and the newly derived phenotypes, reflective of the host innate response including microvascular endothelial dysfunction. However, an integrated subclassification scheme demonstrated varying survival probabilities when comparing patient endophenotypes.

conclusionsOur research underscores the reproducibility of latent profile analyses to identify pediatric septic shock phenotypes with high prognostic relevance. Pending validation, an integrated subclassification scheme, reflective of the different facets of the host response, holds promise to inform targeted intervention among those critically ill.

Indexed as

PhenotypeShock, SepticAdolescentBiomarkersChildChild, PreschoolCohort StudiesFemaleGene Expression ProfilingHumansInfantMaleProspective StudiesTranscriptomeBiomarkersEndotypePhenotypePrecision medicineSepsis

Identifiers

PMID39014377
PMCPMC11253460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.